Warrell Raymond P Jr

Avg. Two Year Performance

(33%) Avg. Purchase Return
(15%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return16%(1%)5%(7%)(33%)
Purchase Success Rate3 of 72 of 71 of 72 of 70 of 7
Average Sale Return23%27%54%73%0%
Sale Success Rate4 of 74 of 74 of 72 of 70 of 7
Drugs » Biotechnology

Chairman & CEO, Director:

Holdings: 2.15B shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--